Clinical trial NCT00553163 - References

Ulcerative Colitis — Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial

Citation(s)

•   Anbar RD
  Self-hypnosis for the treatment of functional abdominal pain in childhood. Clin Pediatr (Phila). 2001 Aug;40(8):447-51.
•   BARON JH, CONNELL AM, LENNARD-JONES JE
  VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS. Br Med J. 1964 Jan 11;1(5375):89-92.
•   Bergman R, Parkes M
  Systematic review: the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol Ther. 2006 Apr 1;23(7):841-55. Review.
•   Bitton A, Sewitch MJ, Peppercorn MA, deB Edwardes MD, Shah S, Ransil B, Locke SE
  Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol. 2003 Oct;98(10):2203-8.
•   Conroy SP, Mayberry JF
  Patient information booklets for Asian patients with ulcerative colitis. Public Health. 2001 Nov;115(6):418-20.
•   Emmanuel AV, Storrie JB, Butcher L et al
  Is targeting locus of control a desirable outcome of biofeedback in functional constipation ? Gut 2007;56, suppl 11:A63.
•   Ewer TC, Stewart DE
  Improvement in bronchial hyper-responsiveness in patients with moderate asthma after treatment with a hypnotic technique: a randomised controlled trial. Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1129-32.
•   Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, Shaikh M, Banan A, Fields JZ
  Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol. 2005 Aug;100(8):1796-804.
•   Friedman H, Taub HA
  The use of hypnosis and biofeedback procedures for essential hypertension. Int J Clin Exp Hypn. 1977 Oct;25(4):335-47.
•   Garrett VD, Brantley PJ, Jones GN, McKnight GT
  The relation between daily stress and Crohn's disease. J Behav Med. 1991 Feb;14(1):87-96.
•   Gonsalkorale WM, Houghton LA, Whorwell PJ
  Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol. 2002 Apr;97(4):954-61.
•   Gonsalkorale WM, Whorwell PJ
  Hypnotherapy in the treatment of irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005 Jan;17(1):15-20. Review.
•   Greene BR, Blanchard EB, Wan CK
  Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther. 1994 Feb;32(2):217-26.
•   Gruzelier J, Smith F, Nagy A, Henderson D
  Cellular and humoral immunity, mood and exam stress: the influences of self-hypnosis and personality predictors. Int J Psychophysiol. 2001 Aug;42(1):55-71.
•   Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C
  A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989 Mar;96(3):804-10.
•   Hawthorne AB, Logan RF, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET, Scott BB, Lennard-Jones JE
  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ. 1992 Jul 4;305(6844):20-2.
•   Hilgard ER, Weitzenhoffer AM, Gough P
  INDIVIDUAL DIFFERENCES IN SUSCEPTIBILITY TO HYPNOSIS. Proc Natl Acad Sci U S A. 1958 Dec 15;44(12):1255-9.
•   Horne DJ, White AE, Varigos GA
  A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol. 1989 Sep;62 ( Pt 3):241-8.
•   Kiecolt-Glaser JK, Marucha PT, Atkinson C, Glaser R
  Hypnosis as a modulator of cellular immune dysregulation during acute stress. J Consult Clin Psychol. 2001 Aug;69(4):674-82.
•   Langewitz W, Izakovic J, Wyler J, Schindler C, Kiss A, Bircher AJ
  Effect of self-hypnosis on hay fever symptoms - a randomised controlled intervention study. Psychother Psychosom. 2005;74(3):165-72.
•   Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, Arcà M, Berto E, Milite G, Marcheggiano A
  Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000 May;95(5):1213-20.
•   Maunder RG, Greenberg GR, Hunter JJ, Lancee WJ, Steinhart AH, Silverberg MS
  Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress. Am J Gastroenterol. 2006 Nov;101(11):2546-51. Epub 2006 Oct 4.
•   Mawdsley JE, Jenkins D, Macey MG, Rampton DS
  Hypnotherapy decreases rectal mucosal release of substance P, histamine and IL-13 in patients with active UC. Gut 2006; 55 (Suppl II): A75
•   Mawdsley JE, Jenkins D, Macey MG, Rampton DS
  Natural Killer cells are increased by psychological stress and decreased by hypnotherapy in ulcerative colitis. Gut 2005; 54 (Suppl II): A23
•   Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS
  The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006 Aug;131(2):410-9.
•   Mawdsley JE, Rampton DS
  Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005 Oct;54(10):1481-91. Review.
•   Mawdsley JE, Rampton DS
  Serum IL-13 concentrations are raised in active ulcerative colitis and correlate with disease activity and mucosal inflammation. Gut 2005; 54 (Suppl IV): A165
•   Naito A, Laidlaw TM, Henderson DC, Farahani L, Dwivedi P, Gruzelier JH
  The impact of self-hypnosis and Johrei on lymphocyte subpopulations at exam time: a controlled study. Brain Res Bull. 2003 Dec 30;62(3):241-53.
•   Rampton DS, Shanahan S
  Fast facts: Inflammatory Bowel Disease. Health Press, 2nd ed, 2006.
•   Reynaert C, Janne P, Donckier J, Buysschaert M, Zdanowicz N, Lejeune D, Cassiers L
  Locus of control and metabolic control. Diabete Metab. 1995 Jun;21(3):180-7.
•   Shertzer CL, Lookingbill DP
  Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol. 1987 Jul;123(7):913-6.
•   Shetty A, Kalantzis C, Polymeros D, Vega R, Abraham S, Forbes A
  Hypnotherapy for inflammatory bowel disease- a randomised, placebo-controlled trial. Gut 2004;53:A226
•   Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I
  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000 Jul;119(1):15-22.
•   Toomey TC, Mann JD, Abashian S, Thompson-Pope S
  Relationship between perceived self-control of pain, pain description and functioning. Pain. 1991 May;45(2):129-33.
•   van Toorenenbergen AW, Oranje AP
  Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis. Clin Chim Acta. 2005 Sep;359(1-2):72-7.
•   Velayos FS, Terdiman JP, Walsh JM
  Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol. 2005 Jun;100(6):1345-53.
•   Wallston BS, Wallston KA, Kaplan GD, Maides SA
  Development and validation of the health locus of control (HLC) scale. J Consult Clin Psychol. 1976 Aug;44(4):580-5.
•   Walmsley RS, Ayres RC, Pounder RE, Allan RN
  A simple clinical colitis activity index. Gut. 1998 Jul;43(1):29-32.
•   Whorwell PJ, Prior A, Faragher EB
  Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet. 1984 Dec 1;2(8414):1232-4.
•   Wood GJ, Bughi S, Morrison J, Tanavoli S, Tanavoli S, Zadeh HH
  Hypnosis, differential expression of cytokines by T-cell subsets, and the hypothalamo-pituitary-adrenal axis. Am J Clin Hypn. 2003 Jan;45(3):179-96.
•   Zachariae R, Hansen JB, Andersen M, Jinquan T, Petersen KS, Simonsen C, Zachariae C, Thestrup-Pedersen K
  Changes in cellular immune function after immune specific guided imagery and relaxation in high and low hypnotizable healthy subjects. Psychother Psychosom. 1994;61(1-2):74-92.
•   Zijlstra FJ, van den Berg-de Lange I, Huygen FJ, Klein J
  Anti-inflammatory actions of acupuncture. Mediators Inflamm. 2003 Apr;12(2):59-69. Review.
•   Zocco MA, dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M, Novi M, Rigante D, Cazzato IA, Ojetti V, Armuzzi A, Gasbarrini G, Gasbarrini A
  Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1567-74.

Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial

Details for clinical trial NCT00553163